- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/53 - Facteur stimulant les colonies [CSF]
Détention brevets de la classe C07K 14/53
Brevets de cette classe: 97
Historique des publications depuis 10 ans
|
6
|
3
|
8
|
7
|
8
|
5
|
4
|
6
|
5
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| King's College London | 573 |
8 |
| Shattuck Labs, Inc. | 121 |
5 |
| Orikine Bio SL | 6 |
4 |
| The Regents of the University of California | 20815 |
3 |
| Fundacio Centre de Regulacio Genomica | 69 |
3 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 21 |
2 |
| The Trustees of the University of Pennsylvania | 4423 |
2 |
| B.G. Negev Technologies and Applications Ltd., at Ben-gurion University | 383 |
2 |
| The Governing Council of The University of Toronto, | 1547 |
2 |
| Hanmi Science Co., Ltd. | 135 |
2 |
| Icahn School of Medicine at Mount Sinai | 1045 |
2 |
| Institucio Catalana de Recerca I Estudis Avancats (ICREA) | 105 |
2 |
| Les Hopitaux Universitaires de Geneve | 45 |
2 |
| Memorial Sloan-Kettering Cancer Center | 2051 |
2 |
| The National Institute for Biotechnology in The Negev Ltd. | 107 |
2 |
| Nektar Therapeutics | 402 |
2 |
| New York University | 1845 |
2 |
| The Scripps Research Institute | 1344 |
2 |
| Universite de Geneve | 250 |
2 |
| Westfalische Wilhelms-universitat Munster | 186 |
2 |
| Autres propriétaires | 44 |